journal article·2026

A sulfonated diblock copolymer exhibits reversible antiplatelet activity and enables aqueous dipyridamole formulation

Aleksandra Frackiewicz, Karol Depczynski, Magdalena Obłoza, Shin-ichi Yusa, Amarjargal Altangerel, Amir Fahmi, Dariusz Pawlak, Krzysztof Szczubiałka, Andrzej Mogielnicki, Bartlomiej Kalaska

Biomaterials Science· Volume 14· Issue 13
Publisher page

Abstract

Sulfonated block copolymers modulate biological function via charge-charge interactions. We report a sulfonated diblock copolymer - poly(sodium styrene sulfonate)-poly(sodium acrylamido undecanoate) (PSSNa38-b-PAaU10) with intrinsic charge-mediated platelet inhibition, and externally triggered reversibility, which also stabilizes poorly water-soluble dipyridamole in aqueous media. The amphiphilic architecture facilitated complete encapsulation at 5 wt% loading through block segregation and hydrophobic domain formation. Screening identified PSSNa38-b-PAaU10 as the most potent inhibitor of platelet aggregation in vitro. The antiplatelet activity of polymer-dipyridamole complex was mediated by the sulfonated block rather than the small molecule. Inhibition persisted under static and flow conditions, confirmed by scanning electron microscopy and lactate dehydrogenase release assay, without evidence of acute cytotoxicity. Polymer-mediated effects were attenuated via polyelectrolyte complexation with a cationic heparin-binding copolymer, enabling reversible regulation of platelet function without directly neutralizing dipyridamole. Ex vivo analyses performed after intravenous administration confirmed antiplatelet efficacy. These findings establish PSSNa38-b-PAaU10 as a diblock copolymer with intrinsic and reversibly controlled antiplatelet activity that also supports aqueous dipyridamole formulation, providing a basis for responsive antithrombotic systems.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Polymer Surface Interaction Studies · Advanced Battery Materials and Technologies · Conducting polymers and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C St., 15-089 Bialystok, Poland

Faculty of Chemistry, Jagiellonian University, Gronostajowa 2 St., 30-387 Krakow, Poland

Department of Applied Chemistry, Graduate School of Engineering, University of Hyogo, 167 Shosha, Himeji 671-2280, Japan

Faculty of Technology and Bionics, Rhine-Waal University of Applied Sciences, Marie-Curie-Str. 1, 47533 Kleve, Germany

Funding

Uniwersytet Medyczny w Bialymstoku

References (60)

Show source-provided references
1. Sierra · Blood Coagul. Fibrinolysis · 2022 · 33 · S110.1097/MBC.0000000000001099 ↗
2. Mackman · Nat. Rev. Drug Discovery · 2020 · 19 · 33310.1038/s41573-020-0061-0 ↗
3. Vrints · Eur. Heart J. · 2024 · 45 · 341510.1093/eurheartj/ehae177 ↗
4. Khorsandi · Clin. Cardiol. · 2024 · 47 · e2428410.1002/clc.24284 ↗
5. Capodanno · JACC Cardiovasc. Interv. · 2023 · 16 · 110.1016/j.jcin.2022.10.023 ↗
6. Zwart · Neth. Heart J. · 2024 · 32 · 33810.1007/s12471-024-01896-2 ↗
7. Swieton · Adv. Healthcare Mater. · 2024 · 13 · 240219110.1002/adhm.202402191 ↗
8. Swieton · Biomater. Sci. · 2025 · 13 · 475710.1039/D5BM00406C ↗
9. Kalaska · Biomacromolecules · 2018 · 19 · 310410.1021/acs.biomac.8b00691 ↗
10. Jansen · J. Thorac. Cardiovasc. Surg. · 1995 · 110 · 82910.1016/S0022-5223(95)70117-6 ↗
11. De Somer · Eur. J. Cardiothorac. Surg. · 2000 · 18 · 60210.1016/S1010-7940(00)00508-X ↗
12. Vang · J. Extra. Corpor. Technol. · 2005 · 37 · 2310.1051/ject/200537023 ↗
13. Vora · Pharm. Dev. Technol. · 2016 · 21 · 84710.3109/10837450.2015.1069330 ↗
14. Onoue · Int. J. Pharm. · 2012 · 426 · 6110.1016/j.ijpharm.2012.01.014 ↗
15. Lu · Int. J. Pharm. · 2025 · 679 · 12573910.1016/j.ijpharm.2025.125739 ↗
16. Guo · Eur. J. Pharm. Biopharm. · 2023 · 184 · 13910.1016/j.ejpb.2023.01.018 ↗
17. Yi · J. Mol. Struct. · 2024 · 1296 · 13683810.1016/j.molstruc.2023.136838 ↗
18. Kalaska · Transl. Res. · 2016 · 177 · 9810.1016/j.trsl.2016.06.009 ↗
19. Kalaska · J. Pharmacol. Exp. Ther. · 2020 · 373 · 5110.1124/jpet.119.262931 ↗
20. Swieton · Int. J. Mol. Sci. · 2021 · 22 · 1114910.3390/ijms222011149 ↗
21. Jakimczuk · J. Clin. Med. · 2022 · 11 · 223610.3390/jcm11082236 ↗
22. Frackiewicz · Thromb. J. · 2023 · 21 · 5810.1186/s12959-023-00501-7 ↗
23. Amiji · Colloids Surf., B · 1998 · 10 · 26310.1016/S0927-7765(98)00005-8 ↗
24. Han · Int. J. Biol. Macromol. · 2005 · 36 · 20110.1016/j.ijbiomac.2005.06.003 ↗
25. Botwina · Pharmaceutics · 2022 · 14 · 30910.3390/pharmaceutics14020309 ↗
26. Swieton · Eur. Polym. J. · 2023 · 199 · 11245210.1016/j.eurpolymj.2023.112452 ↗
27. Mahony · Clin. Pharmacol. Ther. · 1982 · 31 · 33010.1038/clpt.1982.42 ↗
28. Terhaag · Int. J. Clin. Pharmacol. Ther. Toxicol. · 1986 · 24 · 298
29. Betageri · J. Pharm. Pharmacol. · 1993 · 45 · 93110.1111/j.2042-7158.1993.tb05627.x ↗
30. Mizusaki · Polymers · 2017 · 9 · 36710.3390/polym9080367 ↗
31. Karanikolopoulos · Biomacromolecules · 2010 · 11 · 43010.1021/bm901151g ↗
32. Gresele · Br. J. Clin. Pharmacol. · 2011 · 72 · 63410.1111/j.1365-2125.2011.04034.x ↗
33. Kaikita · Thromb. Haemost. · 2019 · 119 · 155410.1055/s-0039-1693411 ↗
34. Bhatt · N. Engl. J. Med. · 2019 · 380 · 182510.1056/NEJMoa1901778 ↗
35. Bhatt · NEJM Evid. · 2022 · 1 · EVIDoa210004710.1056/EVIDoa2100047 ↗
36. Ortega-Paz · Clin. Pharmacokinet. · 2023 · 62 · 67310.1007/s40262-023-01245-3 ↗
37. Kamiński · MedChemComm · 2014 · 5 · 48910.1039/c3md00374d ↗
38. Kalaska · PLoS One · 2015 · 10 · e011948610.1371/journal.pone.0119486 ↗
39. Shenoi · Sci. Transl. Med. · 2014 · 6 · 260ra15010.1126/scitranslmed.3009427 ↗
40. Zong · J. Mater. Chem. B · 2022 · 10 · 326810.1039/D2TB00174H ↗
41. Bonhomme · Platelets · 2015 · 26 · 32410.3109/09537104.2015.1035247 ↗
42. Martin · Eur. J. Anaesthesiol. · 2016 · 33 · 36110.1097/EJA.0000000000000348 ↗
43. Zhang · Transfusion · 2019 · 59 · 185010.1111/trf.15219 ↗
44. Angheloiu · JACC Basic Transl. Sci. · 2017 · 2 · 13510.1016/j.jacbts.2017.01.007 ↗
45. Harker · Thromb. Res. Suppl. · 1983 · 4 · 3910.1016/0049-3848(83)90356-0 ↗
46. Kim · Arterioscler., Thromb., Vasc. Biol. · 2008 · 28 · s3910.1161/ATVBAHA.107.148817 ↗
47. Owen · Nano Today · 2012 · 7 · 5310.1016/j.nantod.2012.01.002 ↗
48. Ghezzi · J. Controlled Release · 2021 · 332 · 31210.1016/j.jconrel.2021.02.031 ↗
49. Huang · Biomacromolecules · 2014 · 15 · 445510.1021/bm501245v ↗
50. Wang · Cellulose · 2010 · 17 · 95310.1007/s10570-010-9441-7 ↗
51. Yu · ACS Appl. Mater. Interfaces · 2020 · 12 · 4682710.1021/acsami.0c15729 ↗
52. Lever · Br. J. Pharmacol. · 2000 · 129 · 53310.1038/sj.bjp.0703099 ↗
53. Dernedde · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 1967910.1073/pnas.1003103107 ↗
54. European Medicines Agency (EMA) . Development of block-copolymer-micelle medicinal products. EMA/CHMP/13099/2013. Available at: https://www.ema.europa.eu/en/development-block-copolymer-micelle-medicinal-products-scientific-guideline
55. Allmeroth · Biomacromolecules · 2011 · 12 · 284110.1021/bm2005774 ↗
56. Park · Cancer Res. Treat. · 2017 · 49 · 56910.4143/crt.2016.289 ↗
57. Mizusaki · Polymers · 2016 · 8 · 5610.3390/polym8020056 ↗
58. Yusa · Macromolecules · 2002 · 35 · 524310.1021/ma0200930 ↗
59. Amarjargal · Biomater. Sci. · 2023 · 11 · 550210.1039/D3BM00837A ↗
60. Amarjargal · Mater. Des. · 2026 · 261 · 11536710.1016/j.matdes.2025.115367 ↗